Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2020 Oct;42(7):e637–e640. doi: 10.1097/MPH.0000000000001604

Table 2:

ALL patients categorized as obese at any point during treatment trended to have worse neuropathy. A mixed effect model was used to look at the effect of weight over time on TNS over time. At any time point during treatment if a patient was categorized as obese, they showed a trend in having worse neuropathy (p=0.0772 marginal significance). The effect of obesity on TNS decreases over time (significant interaction effect with a negative sign p=0.0218).

Effect Estimate Standard Error DF T Value P-value
Month 0.03633 0.02845 397 1.28 0.2024
Weight (Obese vs. Healthy) 1.1195 0.6317 397 1.77 0.0772
Month*Weight (Obese vs. Healthy) −0.1293 0.05614 397 −2.30 0.0218